Today's Stock Analyst Initiations and New Coverage

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AGMB AgomAb Therapeutics	Initiated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick R. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.07 +10.0%	$35.00	Buy
ALT Altimmune	Initiated by	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.92 +8.0%	$10.00	Outperform
ANL Adlai Nortye	Initiated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Li Watsek Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.56 +4.5%		Overweight
BBOT BridgeBio Oncology Therapeutics	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mazahir Alimohamed Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.82 +3.4%	$22.00	Outperform
BILL BILL	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jared Levine Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.68 -2.4%	$43.00	Buy
BYD Boyd Gaming	Initiated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Hickey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$86.43 +2.1%	$100.00	Buy
CASY Casey's General Stores	Initiated by	Capital One Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$831.48 -1.3%	$896.00	Equal Weight
CIZN Citizens	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.25 -1.3%		Market Outperform
CNXU Conexeu Sciences	Initiated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.23 -7.9%	$20.00	Buy
CRDO Credo Technology Group	Initiated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$300.06 +10.4%	$325.00	Outperform
Buy this stock today (Ad) Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to move out of overpriced AI stocks before the tech trade breaks down and into lesser-known names with real potential to challenge the Mag 7. One pick he calls 'an upgrade to Tesla stock' is a little-known company that just inked a partnership with Nvidia, positioning it ahead of Tesla in the autonomous vehicle race. Get the name, ticker, and full Hotlist before markets open
DAR Darling Ingredients	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$53.03 -1.2%	$58.00	Equal Weight
DAR Darling Ingredients	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Theresa Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$53.03 -1.2%	$58.00	Equal Weight
DCH American Axle & Manufacturing	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dan Levy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.15 -2.6%	$8.00	Equal Weight
EL Estee Lauder Companies	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bonnie Herzog Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$85.35 +0.6%	$100.00	Buy
FPLSF 5N Plus	Initiated by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$28.61 -2.5%		Outperform
FTH Sensei Biotherapeutics	Initiated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick R. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.96 +28.8%	$60.00	Buy
GPN Global Payments	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Faucette Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$65.40 -2.2%	$65.00	Overweight ➝ Equal Weight
JETMF Global Crossing Airlines Group	Initiated by	Litchfield Hills Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$0.67 -8.5%		Buy
MUSA Murphy USA	Initiated by	Capital One Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$553.03 +0.3%	$710.00	Overweight
NRC National Research	Initiated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Constantine Davides Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.16 +3.3%	$23.00	Market Outperform
SPCX SpaceX	Initiated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Leshock Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$158.82 -14.1%		Sector Weight
SPCX SpaceX	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$158.82 -14.1%		Buy
SPCX SpaceX	Initiated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$158.82 -14.1%		Buy
TENX Tenax Therapeutics	Initiated by	Chardan Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gautam Chukka Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.12 +1.0%	$27.00	Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 03:25 PM ET.

Frequently Asked Questions

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Analyst Initiations

Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Stock Analyst Initiations

Frequently Asked Questions

What are analyst ratings?

Should you trust analyst ratings?

What does an analyst rating tell you about a stock?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools